- Home
- NRSN vs CCM Comparison
NRSN vs CCM Comparison
Compare NRSN & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- CCM
- Stock Information
- Founded
- NRSN 2017
- CCM 1997
- Country
- NRSN Israel
- CCM China
- Employees
- NRSN N/A
- CCM N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- NRSN Health Care
- CCM Health Care
- Exchange
- NRSN Nasdaq
- CCM Nasdaq
- Market Cap
- NRSN 26.3M
- CCM 25.1M
- IPO Year
- NRSN 2021
- CCM 2009
- Fundamental
- Price
- NRSN $1.31
- CCM $5.08
- Analyst Decision
- NRSN
- CCM
- Analyst Count
- NRSN 0
- CCM 0
- Target Price
- NRSN N/A
- CCM N/A
- AVG Volume (30 Days)
- NRSN 181.1K
- CCM 6.1K
- Earning Date
- NRSN 11-26-2024
- CCM 11-22-2024
- Dividend Yield
- NRSN N/A
- CCM N/A
- EPS Growth
- NRSN N/A
- CCM N/A
- EPS
- NRSN N/A
- CCM N/A
- Revenue
- NRSN N/A
- CCM $64,910,622.00
- Revenue This Year
- NRSN N/A
- CCM N/A
- Revenue Next Year
- NRSN N/A
- CCM N/A
- P/E Ratio
- NRSN N/A
- CCM N/A
- Revenue Growth
- NRSN N/A
- CCM N/A
- 52 Week Low
- NRSN $0.47
- CCM $3.80
- 52 Week High
- NRSN $2.33
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- NRSN 61.44
- CCM 33.74
- Support Level
- NRSN $1.23
- CCM $4.47
- Resistance Level
- NRSN $1.34
- CCM $9.07
- Average True Range (ATR)
- NRSN 0.10
- CCM 0.72
- MACD
- NRSN 0.01
- CCM -0.32
- Stochastic Oscillator
- NRSN 75.00
- CCM 21.37
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.